Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study

Autor: Mohammed J. Alramadan, Dianna J. Magliano, Liaquat Ali, Samira Humaira Habib, Khurshid Alam, Baki Billah, Afsana Afroz, Afsana Karim
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Adult
Male
medicine.medical_specialty
Type 2 diabetes
Direct cost
Comorbidity
Drug Costs
Health administration
Diabetes Complications
Interviews as Topic
03 medical and health sciences
Indirect costs
0302 clinical medicine
Cost of Illness
Diabetes management
Diabetes mellitus
Surveys and Questionnaires
Health care
medicine
Prevalence
Humans
030212 general & internal medicine
health care economics and organizations
Qualitative Research
Aged
Bangladesh
business.industry
lcsh:Public aspects of medicine
030503 health policy & services
Health Policy
Medical record
Cost-of-illness
Type 2 Diabetes Mellitus
lcsh:RA1-1270
Middle Aged
medicine.disease
Cross-Sectional Studies
Diabetes Mellitus
Type 2
Indirect cost
Emergency medicine
Female
0305 other medical science
business
Burden of diabetes
Management plan
Research Article
Zdroj: BMC Health Services Research
BMC Health Services Research, Vol 19, Iss 1, Pp 1-12 (2019)
ISSN: 1472-6963
Popis: Background The economic burden of type 2 diabetes has not been adequately investigated in many low- and lower middle-income countries, including Bangladesh. The aim of this study was to estimate the cost-of-illness of type 2 diabetes and to find its determinants in Bangladesh. Methods A cross-sectional study was conducted in 2017 to recruit 1253 participants with type 2 diabetes from six diabetes hospitals, providing primary to tertiary health care services, located in the northern and central regions of Bangladesh. A structured questionnaire was used for face-to-face interviewing to collect non-clinical data. Patients’ medical records were reviewed for clinical data and hospital records were reviewed for hospitalisation data. Cost was calculated from the patient’s perspective using a bottom-up methodology. The direct costs for each patient and indirect costs for each patient and their attendants were calculated. The micro-costing approach was used to calculate direct cost and the human capital approach was used to calculate indirect cost. Median regression analysis was performed to identify the determinants of average annual cost. Results Among the participants, 54% were male. The mean (±SD) age was 55.1 ± 12.5 years and duration of diabetes was 10.7 ± 7.7 years. The average annual cost was US$864.7 per patient. Medicine cost accounted for 60.7% of the direct cost followed by a hospitalisation cost of 27.7%. The average annual cost for patients with hospitalisation was 4.2 times higher compared to those without hospitalisation. Being females, use of insulin, longer duration of diabetes, and presence of diabetes complications were significantly related to the average annual cost per patient. Conclusions The cost of diabetes care is considerably high in Bangladesh, and it is primarily driven by the medicine and hospitalisation costs. Optimisation of diabetes management by positive lifestyle changes is urgently required for prevention of comorbidities and complications, which in turn will reduce the cost. Electronic supplementary material The online version of this article (10.1186/s12913-019-4440-3) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE
Externí odkaz: